Ansun Biopharma Inc dba Ansun
- View government funding actions
- San Diego, CA 92121
- Phone: 858-452-2631
- Corporate URL: www.ansunbiopharma.com/
- Estimated Number of Employees: 25
- Estimated Annual Receipts: $10,000,000
- Business Start Date: 2003
- Contact Person: Michael Havluciyan
- Contact Phone: 858-452-2631
- Contact Email: mhavluciyan@ansunbiopharma.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- Minority Owned Business
- For Profit Organization
- Asian-Pacific American Owned
- Industries Served:
- Product Areas: SURGICAL DRESSING MATERIALS, MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES, MED & SURGICAL INSTRUMENTS,EQ & SUP, DENTAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES, DENTAL INSTRUMENTS EQ & SUPPLIES, IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY, X-RAY EQ SUPPLIES - MED, DENTAL & V, HOSP FURNITURE,EQ,UTENSILS & SUP, HOSPITAL FURNITURE, EQUIPMENT, UTENSILS, AND SUPPLIES, HOSPITAL & SURGICAL CLOTHING, HOSPITAL AND SURGICAL CLOTHING AND RELATED SPECIAL PURPOSE ITEMS, OPHTHALMIC INSTRUMENTS, EQUIPMENT, AND SUPPLIES, OPTHALMIC INSTRUMENTS EQ & SUPPLIES, REPLENISHABLE FIELD MEDICAL SETS, KITS, AND OUTFITS, MEDICAL SETS KITS & OUTFITS, IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS, IN VITRO DIAGNO SUBSTANCES,REAGENTS, LABORATORY EQUIPMENT AND SUPPLIES, OPTICAL INSTRUMENTS, OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES, HAZARD-DETECTING INSTRU & APPARATUS, HAZARD-DETECTING INSTRUMENTS AND APPARATUS, SCALES AND BALANCES, CABINETS, LOCKERS, BINS, AND SHELVING, CABINETS LOCKERS BINS & SHELVING
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $26,504,502 - Saturday the 1st of August 2015
Office Of Assistant Secretary For Administration And Management
OFF ASST SEC ADM AND MGMT
DAS181: A BROAD-SPECTRUM ANTIVIRAL THERAPEUTIC FOR TREATMENT OF INFLUENZA A AND B VIRUS INFECTIONS
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.